Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | 7 | 1 | 1 | 0 | €117.05 | €147.62 | 26.114% |
| Edwards Lifesciences Corp. | 27 | 1 | 4 | 0 | €81.08 | €88.17 | 8.744% |
| US Physical Therapy Inc. | 8 | 1 | 1 | 0 | €94.50 | €109.94 | 16.343% |
| Cytokinetics Inc. | 31 | 1 | 8 | 0 | €44.60 | €83.13 | 86.393% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €10.28 | €27.80 | 170.467% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | €37.40 | €84.74 | 126.588% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.52 | €3.70 | 143.902% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.92 | €6.45 | 236.775% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €119.40 | €124.93 | 4.631% |
| CONMED Corp. | 11 | 1 | 4 | 0 | €69.00 | €106.18 | 53.883% |
| UnitedHealth Group Inc. | 33 | 1 | 0 | 0 | €468.50 | €543.72 | 16.055% |
| Henry Schein Inc. | 12 | 1 | 1 | 0 | €66.12 | €79.48 | 20.204% |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | €33.60 | €56.62 | 68.504% |
| Bruker Corp. | 7 | 1 | 1 | 0 | €71.20 | €84.02 | 18.011% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €22.91 | €60.55 | 164.313% |
| Insmed Inc. | 18 | 1 | 5 | 1 | €21.80 | €44.16 | 102.591% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €5.95 | €10.00 | 68.067% |
| Natural Alternat. | 18 | 1 | 1 | 0 | €5.90 | - | - |
| Molina Healthcare | 12 | 1 | 1 | 0 | €306.10 | €366.73 | 19.806% |
| Staar Surgical Co. | 12 | 1 | 1 | 0 | €39.03 | €49.33 | 26.383% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €21.40 | €32.58 | 52.238% |
| Biogen Inc. | 49 | 1 | 8 | 1 | €201.00 | €293.57 | 46.056% |
| Chromadex Corp | 11 | 1 | 1 | 0 | €2.94 | €5.58 | 89.653% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €21.34 | - | - |
| Heron Therapeutics Inc. | 11 | 1 | 3 | 0 | €3.21 | €4.59 | 43.138% |